Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Cuure

Explore full profile

Nutraceutic revolution in personalized nutrition, powered by science and technology

Paris, FranceFounded 2019Food
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Cuure and the history behind them.

About Cuure

Cuure is a direct-to-consumer company in the personalized wellness sector, specializing in tailor-made nutritional supplements. The firm was founded in Paris, France, in 2019 by Hugo Facchin and Jules Marcilhacy. The founders, both sons of doctors, met in New York and combined their e-commerce and growth hacking backgrounds to address a gap in the French dietary supplement market, which they observed often lacked professional advice.

The company's business model is centered on a subscription service for personalized dietary supplements. Revenue is generated through monthly recurring payments for these customized supplement packs. The process begins with a potential customer completing a comprehensive online questionnaire about their lifestyle, health goals, and dietary habits. An algorithm then processes this information to recommend a specific combination of vitamins, minerals, plants, and probiotics from a range of over 30 unique products. Customers receive a monthly box containing 30 daily-dose sachets, which can be adjusted based on evolving needs through regular follow-up questionnaires. This subscription can be suspended at any time. Cuure also offers individual product purchases outside of the subscription model.

The service is designed for a broad audience of health-conscious consumers who seek a more targeted approach to supplementation. Cuure's platform addresses a variety of needs, including energy levels, sleep quality, stress management, and immunity. A key feature is its mobile application, which helps users track their progress and maintain consistency. The company emphasizes the scientific backing of its products, which are formulated by bio-engineers and a scientific committee, using patented and clinically proven ingredients where possible. Production primarily occurs in France and Belgium in ISO 22000 certified laboratories, ensuring food safety standards. The company has demonstrated significant traction, securing a €1.8 million seed round in September 2020 and a $10.2 million Series A round in July 2022 to fuel its European expansion.

Source: Dealroom company data

At a glance

Founded
2019
Headquarters
Paris, France
Sector
Food

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

Series A3 investors entered at this stage

Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
5 countries with
team presence
🇫🇷 France84.4%
🇬🇧 United Kingdom6.3%
🇪🇸 Spain3.1%
🇺🇸 United States3.1%
🇻🇳 Vietnam3.1%
5 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Cuure on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Cuure on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.